Silk Road Medical to Present at the Morgan Stanley 2020 Healthcare Conference
SUNNYVALE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the […]
Kitov Pharma Receives Notice of Intention to Grant Two Patents in China Covering Company’s Lead Oncology Assets, CM24 and NT219
Kitov’s patent coverage for CM24 and NT219 now extends to the U.S., EU, China, and multiple ROW countriesTEL AVIV, Israel, […]
UNITY Biotechnology to Participate in Upcoming September Investor Conferences
SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan […]
Fate Therapeutics Announces September Investor Events
SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the […]
Hurco Reports Profitable Results for Third Quarter of Fiscal 2020
INDIANAPOLIS, Sept. 04, 2020 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter […]
Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology
SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study
SAN JOSE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
DraftKings Announces Jason Robins’ Participation in Upcoming Virtual Investor & Industry Conferences
BOSTON, Sept. 04, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that Jason Robins, co-founder, Chief Executive Officer […]
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH and Hypoparathyroidism at 22nd European Congress of Endocrinology
COPENHAGEN, Denmark, Sept. 04, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]
Cyclerion to Participate at Upcoming September 2020 Investor Conferences
CAMBRIDGE, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the […]
